user

Efficacy of capecitabine vs. infusional 5-FU as neoadjuvant chemoradiotherapy for rectal cancer

被引：0
|
作者：
Kocakova, I [1 ]
Kubala, E. [2 ]
Spurny, V
Dvorak, J.
Finek, J. [3 ]
Cwiertka, K. [4 ]
Prausova, J. [2 ]
Hoch, J. [2 ]
Vyzula, R. [1 ]
机构：
[1] Masaryk Oncol Inst, Brno, Czech Republic
[2] Fac Hosp Motol, Prague, Czech Republic
[3] Fac Hosp Plzen, Plzen, Czech Republic
[4] Fac Hosp Olomouc, Olomouc, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] NEOADJUVANT CAPECITABINE- VS. INFUSIONAL 5-FU-BASED CHEMORADIATION FOR RECTAL CANCER: EFFICACY UPDATE
    Prausova, J.
    Kocakova, I
    Kubala, E.
    Spumy, V
    Dvorak, J.
    Finek, J.
    Cwiertka, K.
    Hoch, J.
    Vyzula, R.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 110 - 110
  • [2] CHEMORADIOTHERAPY WITH 5-FU VERSUS CAPECITABINE ON RECTAL CANCER DOWNSTAGING
    Aguas, L.
    Salgado, M.
    Davila, C.
    Costa, A. S.
    Almeida, D.
    Barbosa, M.
    Caeiro, C.
    Sarmento, C.
    Marques, M.
    Damasceno, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 211 - 211
  • [3] Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
    M. W. Saif
    Shahrukh Hashmi
    Daniel Zelterman
    Khaldoun Almhanna
    Richard Kim
    [J]. International Journal of Colorectal Disease, 2008, 23
  • [4] Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
    Saif, M. W.
    Hashmi, Shahrukh
    Zelterman, Daniel
    Almhanna, Khaldoun
    Kim, Richard
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (02) : 139 - 145
  • [5] Neoadjuvant chemoradiation with capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: A matched pair analysis
    Das, P
    Lin, EH
    Bhatia, S
    Skibber, JM
    Rodriguez-Bigas, MA
    Feig, BW
    Hoff, PM
    Eng, C
    Wolff, RA
    Krishnan, S
    Janjan, NA
    Crane, CH
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S164 - S164
  • [6] Neoadjuvant oral vs. infusional chemoradiotherapy on locally advanced rectal cancer: Prognostic factors
    Conde, Sofia
    Borrego, Margarida
    Teixeira, Tania
    Teixeira, Rubina
    Sa, Anabela
    Soares, Paula
    [J]. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (02) : 67 - 75
  • [7] Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
    A Madi
    D Fisher
    R H Wilson
    R A Adams
    A M Meade
    S L Kenny
    L L Nichols
    M T Seymour
    H Wasan
    R Kaplan
    T S Maughan
    [J]. British Journal of Cancer, 2012, 107 : 1037 - 1043
  • [8] Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
    Madi, A.
    Fisher, D.
    Wilson, R. H.
    Adams, R. A.
    Meade, A. M.
    Kenny, S. L.
    Nichols, L. L.
    Seymour, M. T.
    Wasan, H.
    Kaplan, R.
    Maughan, T. S.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1037 - 1043
  • [9] CAPECITABINE VS. 5-FU AS NEOADJUVANT THERAPY FOR ADVANCED RECTAL ADENOCARCINOMA. IS THERE A DIFFERENCE IN TUMOR REGRESSION GRADE AND DOWNSTAGING OF THE SURGICAL SPECIMEN?
    Edden, Y.
    Shawki, S.
    Blount, S.
    Stone, E.
    Wexner, S.
    Berho, M.
    [J]. DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 614 - 614
  • [10] A comparison of capecitabine versus infusional 5-FU used concurrently with preoperative radiation for rectal cancer: A population-based study
    Lim, H. J.
    Gill, S.
    Hay, J.
    Savage, K. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345